A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Item 1. Business The following Business Section contains forward-looking statements. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain risks, uncertainties and other factors including the risk factors set forth in Part I, Item 1A of this Annual Report on Form 10-K. In this report, “Cyclacel,” the “Company,” “we,” “us,” and “our” refer to Cyclacel Pharmaceuticals, Inc. In December 2024 the Company announced that it was in the process of exploring and reviewing strategic alternatives on an expedited basis in order to preserve the Company’s cash, including a potential transaction with investor David Lazar of Activist Investing, LLC, or “Lazar”. The Company’s Board of Directors reviewed a range of appropriate strategies to realize value from its assets.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 81K | 43K | 420K | 0 | 0 | 0 |
| Net Income | -7.0M | - | - | - | -18M | -8.4M |
| EPS | $-2.91 | $-504.30 | $-6,419.18 | $-27.24 | $-2.09 | $-3.42 |
| Free Cash Flow | 0 | -8.0M | -16M | -21M | -19M | -8.0M |
| ROIC | -88.8% | - | - | - | -49.0% | -25.4% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | -2.88 | 0.06 | 0.01 | 0.00 | 0.03 |
| Dividends/Share | $0.00 | - | $0.23 | $0.15 | $0.02 | $0.02 |
| Operating Income | -9.2M | -12M | -25M | -28M | -22M | -11M |
| Operating Margin | -11324.7% | -27916.3% | -6060.2% | - | - | - |
| ROE | -98.3% | - | - | - | -49.0% | -25.4% |
| Shares Outstanding | 5M | 1M | 1M | 1M | 9M | 10M |
Bio Green Med Solution, Inc. passes 0 of 9 quality checks, indicating weak fundamentals.
Bio Green Med Solution, Inc. (BGMSP) has a 5-year average return on invested capital (ROIC) of -37.2%. This is below average and may indicate limited pricing power.
Bio Green Med Solution, Inc. (BGMSP) has a market capitalization of $5M. It is classified as a small-cap stock.
Bio Green Med Solution, Inc. (BGMSP) does not currently pay a regular dividend.
Bio Green Med Solution, Inc. (BGMSP) operates in the Pharmaceutical Preparations industry, within the Healthcare sector.
Bio Green Med Solution, Inc. (BGMSP) reported annual revenue of $43 thousand in its most recent fiscal year, based on SEC EDGAR filings.
Bio Green Med Solution, Inc. (BGMSP) generated $-8 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Bio Green Med Solution, Inc. (BGMSP) reported earnings per share (EPS) of $-504.30 in its most recent fiscal year.
The Ledger Terminal provides 16 years of financial data for Bio Green Med Solution, Inc. (BGMSP), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Bio Green Med Solution, Inc. (BGMSP) has a book value per share of $-2.52, based on its most recent annual SEC filing.